GYNEZOL: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
GYNEZOL
Largest movements
- Deferred charges and accrued income +€494,443
up €494,443 (+21.9%), from €2.3m to €2.8m
- Cash +€40,196
up €40,196 (+87.9%), from €45,720 to €85,916
- Accrued charges and deferred income +€633,008
up €633,008 (+29.7%), from €2.1m to €2.8m
- Other debts -€87,669
down €87,669 (-53.8%), from €162,991 to €75,323
- Gross operating margin +€20,550
up €20,550 (+55.1%), from €37,272 to €57,822
- Staff costs +€18,456
up €18,456 (+54.7%), from €33,757 to €52,213
- Depreciation +€1,378
up €1,378 (+57.7%), from €2,390 to €3,767
From the 2024 result to the 2025 result
The net result is not in both sets of accounts; without it the difference cannot be explained line by line.
Derived cash bridge
Cash or the result is not a separate line in both sets of accounts; the cash flow cannot be derived from them.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €2,323,485 | €2,856,525 | +€533,039 | +22.9% |
| Fixed assets | 21/28 | €11,677 | €10,077 | -€1,600 | -13.7% |
| Tangible fixed assets | 22/27 | €11,677 | €10,077 | -€1,600 | -13.7% |
| Plant, machinery and equipment | 23 | €6,951 | €7,226 | +€274 | +3.9% |
| Furniture and vehicles | 24 | €4,726 | €2,852 | -€1,875 | -39.7% |
| Current assets | 29/58 | €2,311,808 | €2,846,447 | +€534,640 | +23.1% |
| Amounts receivable within one year | 40/41 | €5,500 | €5,500 | = | 0.0% |
| Other amounts receivable | 41 | €5,500 | €5,500 | = | 0.0% |
| Cash at bank and in hand | 54/58 | €45,720 | €85,916 | +€40,196 | +87.9% |
| Deferred charges and accrued income | 490/1 | €2,260,588 | €2,755,031 | +€494,443 | +21.9% |
| Total equity and liabilities | 10/49 | €2,323,485 | €2,856,525 | +€533,039 | +22.9% |
| Equity | 10/15 | €5,500 | €5,500 | = | 0.0% |
| Contributions | 10/11 | €5,500 | €5,500 | = | 0.0% |
| Amounts payable | 17/49 | €2,317,985 | €2,851,025 | +€533,039 | +23.0% |
| Amounts payable within one year | 42/48 | €186,985 | €87,017 | -€99,968 | -53.5% |
| Trade debts | 44 | €19,519 | €4,418 | -€15,102 | -77.4% |
| Suppliers | 440/4 | €19,519 | €4,418 | -€15,102 | -77.4% |
| Taxes, remuneration and social security | 45 | €4,474 | €7,277 | +€2,802 | +62.6% |
| Taxes | 450/3 | - | €228 | +€228 | |
| Remuneration and social security | 454/9 | €4,474 | €7,048 | +€2,574 | +57.5% |
| Other amounts payable | 47/48 | €162,991 | €75,323 | -€87,669 | -53.8% |
| Accrued charges and deferred income | 492/3 | €2,131,000 | €2,764,008 | +€633,008 | +29.7% |
| Remuneration, social security and pensions | 62 | €33,757 | €52,213 | +€18,456 | +54.7% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €2,390 | €3,767 | +€1,378 | +57.7% |
| Other operating charges | 640/8 | €512 | €661 | +€149 | +29.1% |
| Gross operating margin | 9900 | €37,272 | €57,822 | +€20,550 | +55.1% |
| Operating profit (loss) | 9901 | €613 | €1,180 | +€567 | +92.6% |
| Financial income | 75/76B | €0 | €0 | +€0 | +100% |
| Recurring financial income | 75 | €0 | €0 | +€0 | +100% |
| Financial charges | 65/66B | €613 | €952 | +€339 | +55.4% |
| Recurring financial charges | 65 | €613 | €952 | +€339 | +55.4% |
| Profit (loss) for the period before taxes | 9903 | - | €228 | +€228 | |
| Income taxes | 67/77 | - | €228 | +€228 |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 29 October 2026 via checked.be.